Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cashflow Statement

AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹1,399 Cr₹569 Cr₹868 Cr₹1,441 Cr₹1,382 Cr
Adjustment ₹982 Cr₹1,010 Cr₹1,472 Cr₹787 Cr₹645 Cr
Changes In working Capital ₹-2,529 Cr₹-797 Cr₹-1,074 Cr₹-561 Cr₹-386 Cr
Cash Flow after changes in Working Capital ₹-147 Cr₹782 Cr₹1,266 Cr₹1,667 Cr₹1,641 Cr
Cash Flow from Operating Activities ₹-828 Cr₹-265 Cr₹625 Cr₹1,109 Cr₹1,131 Cr
Cash Flow from Investing Activities ₹2.09 Cr₹4,561 Cr₹-528 Cr₹-333 Cr₹-675 Cr
Cash Flow from Financing Activities ₹787 Cr₹-3,906 Cr₹-77 Cr₹-520 Cr₹-442 Cr
Net Cash Inflow / Outflow ₹-38 Cr₹389 Cr₹19 Cr₹255 Cr₹14 Cr
Opening Cash & Cash Equivalents ₹1,658 Cr₹1,443 Cr₹1,411 Cr₹1,138 Cr₹1,110 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger --₹0.67 Cr--
Cash & Cash Equivalent of Subsidiaries under liquidations -₹-192 Cr---
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹56 Cr₹18 Cr₹12 Cr₹18 Cr₹14 Cr
Closing Cash & Cash Equivalent ₹1,676 Cr₹1,658 Cr₹1,443 Cr₹1,411 Cr₹1,138 Cr

Compare Cashflow Statement of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹57,512.4 Cr -0% 3.4% 48.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,613.0 Cr 0.9% 6.2% 0.6% Stock Analytics
DIVIS LABORATORIES ₹167,105.0 Cr 1.8% 4.8% 6.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,926.0 Cr 1.3% 9.8% 37.7% Stock Analytics
DR REDDYS LABORATORIES ₹109,088.0 Cr 1.7% 5.8% 6.7% Stock Analytics
CIPLA ₹107,120.0 Cr -1.3% 0.9% -8.9% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-0%

3.4%

48.7%

SENSEX

0%

1.2%

9.7%


You may also like the below Video Courses